Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases.

Clinical trial NCT00278954 · COMPLETED

Trial details

NCT number: NCT00278954
Sponsor: Bio Products Laboratory
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Immunodeficiency Common Variable Hypogammaglobulinemia X-linked Hypogammaglobulinemia Hypogammaglobulinemia Immunodeficiency With Hyper-IgM Wiskott-Aldrich Syndrome

Start date: 2006-01-01
Primary completion: 2007-11-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.